What is the role of a "Collaborative Drug Therapy Management" agreement?

The role of a "Collaborative Drug Therapy Management" (CDTM) agreement is primarily to enable pharmacists to manage and modify medication therapy in partnership with physicians. This collaborative approach allows pharmacists to utilize their extensive knowledge in pharmacotherapy to optimize patient outcomes, enhance medication safety, and improve adherence to medication regimens.

In a CDTM agreement, pharmacists and physicians establish a formal relationship that outlines the responsibilities and authority of the pharmacist in making adjustments to a patient's medication regimen. This can include initiating, modifying, or discontinuing medications based on pre-established criteria or clinical guidelines. The integration of pharmacists in this capacity can lead to a more coordinated and comprehensive approach to patient care, facilitating better management of chronic diseases and ensuring that patients receive the most appropriate and effective therapy for their conditions.

The other options do not reflect the true purpose of a CDTM agreement, as they do not encompass the collaborative and therapeutic decision-making element that characterizes this practice.